GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...

GSK plc (LON:GSK – Get Free Report) insider Jonathan Symonds bought 1,500 shares of the stock in a transaction on Friday, December 20th. The shares were acquired at an average cost of GBX 1,315 ...

GSK – Free Report) from a buy rating to a strong-buy rating in a research report report published on Saturday. Other analysts ...

Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff ...